Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Depreciation Expense (2024 - 2026)

Maxcyte has reported Depreciation Expense over the past 2 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Depreciation Expense changed 0.19% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $4.3 million for FY2025, 0.65% down from the prior year.
  • Depreciation Expense was $1.1 million for Q4 2025 at Maxcyte, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Depreciation Expense peaked at $1.1 million in Q2 2025 and troughed at $1.1 million in Q4 2025.